drugset / Trial / NCT02094716
A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies
Phase 2
Completed
130 enrolled
Mylan Inc.
DPT Laboratories, Ltd. · collabVyne Therapeutics Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine and compare the safety and efficacy of permethrin foam 4% and permethrin foam 5% with that of vehicle in subjects with scabies.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Permethrin | Small molecule | 4 % | Topical |
| Subject | Permethrin | Small molecule | 5 % | Topical |